BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12651832)

  • 41. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
    Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
    Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.
    Li Y; Scott CR; Chamoles NA; Ghavami A; Pinto BM; Turecek F; Gelb MH
    Clin Chem; 2004 Oct; 50(10):1785-96. PubMed ID: 15292070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
    Golbahar J; Altayab DD; Carreon E
    J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo measurement of ureagenesis with stable isotopes.
    Yudkoff M; Daikhin Y; Ye X; Wilson JM; Batshaw ML
    J Inherit Metab Dis; 1998; 21 Suppl 1():21-9. PubMed ID: 9686342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic analysis of carbamoylphosphate synthetase I and ornithine transcarbamylase deficiency using fibroblasts.
    Rapp B; Häberle J; Linnebank M; Wermuth B; Marquardt T; Harms E; Koch HG
    Eur J Pediatr; 2001 May; 160(5):283-7. PubMed ID: 11388595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: application to newborn screening.
    deWilde A; Sadilkova K; Sadilek M; Vasta V; Hahn SH
    Clin Chem; 2008 Dec; 54(12):1961-8. PubMed ID: 18845768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partial ornithine transcarbamylase deficiency.
    Riudor E; Arranz JA; Rodés M
    Pediatrics; 2003 May; 111(5 Pt 1):1123-4; author reply 1123-4. PubMed ID: 12728104
    [No Abstract]   [Full Text] [Related]  

  • 48. [Variants of inborn errors of metabolism with late onset but nevertheless life threatening course].
    Plöchl E; Plöchl W; Wermuth B; Roscher AA
    Klin Padiatr; 2001; 213(5):261-5. PubMed ID: 11582523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
    Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
    Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is your diagnosis? An 18-month-old child with ornithine transcarbamylase deficiency and a rash.
    Foster RS; Halbert AR
    Pediatr Dermatol; 2011; 28(4):457-8. PubMed ID: 21793886
    [No Abstract]   [Full Text] [Related]  

  • 51. Prenatal diagnosis of ornithine transcarbamylase deficiency.
    Bale AE
    Prenat Diagn; 1999 Nov; 19(11):1052-4. PubMed ID: 10589058
    [No Abstract]   [Full Text] [Related]  

  • 52. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.
    Brusilow SW
    J Clin Invest; 1984 Dec; 74(6):2144-8. PubMed ID: 6511918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute postpartum mental status change and coma caused by previously undiagnosed ornithine transcarbamylase deficiency.
    Peterson DE
    Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1212-5. PubMed ID: 14607061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early intervention for late-onset ornithine transcarbamylase deficiency.
    Fujisawa D; Mitsubuchi H; Matsumoto S; Iwai M; Nakamura K; Hoshide R; Harada N; Yoshino M; Endo F
    Pediatr Int; 2015; 57(1):e1-3. PubMed ID: 25711267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ornithine transcarbamylase deficiency presenting as hepatitis.
    Aronson PL; Mistry RD
    Pediatr Emerg Care; 2011 Jun; 27(6):527-9. PubMed ID: 21642786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
    la Marca G; Malvagia S; Pasquini E; Innocenti M; Donati MA; Zammarchi E
    Clin Chem; 2007 Jul; 53(7):1364-9. PubMed ID: 17510301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
    Chan JS; Harding CO; Blanke CD
    South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous animal models of ornithine transcarbamylase deficiency: studies on serum and urinary nitrogenous metabolites.
    Qureshi IA; Letarte J; Ouellet R
    Adv Exp Med Biol; 1982; 153():173-83. PubMed ID: 7164896
    [No Abstract]   [Full Text] [Related]  

  • 59. Application of electrospray tandem mass spectrometry to neonatal screening.
    Rashed MS; Rahbeeni Z; Ozand PT
    Semin Perinatol; 1999 Apr; 23(2):183-93. PubMed ID: 10331469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.
    Sander J; Janzen N; Peter M; Sander S; Steuerwald U; Holtkamp U; Schwahn B; Mayatepek E; Trefz FK; Das AM
    Clin Chem; 2006 Mar; 52(3):482-7. PubMed ID: 16439608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.